Search results
Results from the WOW.Com Content Network
Hyperbaric medicine includes hyperbaric oxygen treatment, which is the medical use of oxygen at greater than atmospheric pressure to increase the availability of oxygen in the body; [8] and therapeutic recompression, which involves increasing the ambient pressure on a person, usually a diver, to treat decompression sickness or an air embolism by reducing the volume and more rapidly eliminating ...
Hyperbaric treatment schedules or hyperbaric treatment tables, are planned sequences of events in chronological order for hyperbaric pressure exposures specifying the pressure profile over time and the breathing gas to be used during specified periods, for medical treatment. Hyperbaric therapy is based on exposure to pressures greater than ...
Although diet, exercise, behavior therapy and anti-obesity drugs are first-line treatment, [14] medical therapy for severe obesity has limited short-term success and very poor long-term success. [15] Weight loss surgery generally results in greater weight loss than conventional treatment, and leads to improvements in quality of life and obesity ...
Parathyroidectomy is a curative therapy for symptomatic hyperparathyroidism. Additionally, it decrease the risk of nephrolithiasis, osteoporosis, fragility fractures, and improves bone mineral density. Studies have also found that parathyroidectomy for hyperparathyroidism improves fatigue, weakness, depression, and memory.
The guidelines attempt to address the prevention and management of obesity at both the individual and population levels in both children and adults. [5] The European Union published clinical practice guidelines in 2008 in an effort to address the rising rates of obesity in Europe. [107] Australia came out with practice guidelines in 2004. [106]
A 24-week randomized trial was conducted in postmenopausal women with osteoporosis (n=222) assessing bone mass density (BMD) changes as the primary endpoint. [18] Significant BMD increase at doses of 40 and 80 mcg were found in the lumbar spine , femur and hips of abaloparatide-treated participants compared to placebo .
Sarcopenic obesity is a combination of two disease states, sarcopenia and obesity. Sarcopenia is the muscle mass/strength/physical function loss associated with increased age, [ 1 ] and obesity is based off a weight to height ratio or body mass index (BMI) that is characterized by high body fat or being overweight.
Teriparatide is indicated for the treatment of postmenopausal women with osteoporosis; [13] for the increase of bone mass in men with primary or hypogonadal osteoporosis; [13] and treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy.